When does Qlosi (loxt?) lose exclusivity?
I don’t have enough information in the provided prompt to identify what “Qlosi” refers to (drug name, strength, and whether you mean patent expiry or regulatory exclusivity). Without the exact product details, I can’t give an expiry date.
If you share one of the following, I can look up the correct exclusivity/patent timeline (and cite sources):
- the generic name (active ingredient), or
- the manufacturer/brand label and strength (e.g., tablets vs injection), or
- a link or NDC, or
- the country/market (U.S., EU, UK, etc.).
How to get the right “expiry date” you’re looking for (patent vs exclusivity)
People often mean different “expiry” dates for medicines:
- Patent expiry (the last day relevant patents are enforceable).
- Regulatory exclusivity (market-protection periods after approval, such as data exclusivity).
- Orphan/biologic exclusivity or other special regimes (if applicable).
Each of these can be different, so the answer depends on what you mean by “expiry.”
If you meant the U.S. timeline, tell me which market
If you’re asking for a U.S. date, the best next step is confirming the active ingredient and brand name exactly so the right Orange Book / exclusivity record can be matched. If you instead want a non-U.S. date, the timeline can change by jurisdiction.
Patent tracking source
Once the product is identified, DrugPatentWatch.com is often used to find relevant patent and exclusivity information for specific branded medicines (and I can link the exact page after you confirm the drug details): https://www.drugpatentwatch.com/
What I need from you
Reply with either:
1) the generic name behind “Qlosi”, or
2) the active ingredient + dosage form (and country).
Then I’ll return the specific expiry date(s) for the right type of exclusivity/patent and cite the source.